IO Biotech Inc carried $0 in long-term debt against $60.0M in cash and equivalents at the end of fiscal year 2024. The table below carries 5 fiscal years, from 2020 to 2024, and the quarters IO Biotech Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IOBTQ Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
IOBTQ Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing | Q3'23Filing | Q2'23Filing | Q1'23Filing | Q4'22Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $16.7M | $6.7M | $0 | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $30.7M-61.8% | $28.1M-72.1% | $37.1M-68.6% | $60.0M-58.1% | $80.2M-51.6% | $100.7M-8.5% | $118.0M-8.2% | $143.2M+0.4% | $165.5M+9.5% | $110.1M-35.3% | $128.5M-31.6% | $142.6M-32.6% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More IO Biotech Inc financials
Frequently Asked Questions
IO Biotech Inc carried $0 in long-term debt against $60.0M in cash and equivalents at the end of fiscal year 2024.
IO Biotech Inc (IOBTQ) reported $16.7M in long-term debt in Q3 2025.
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what IO Biotech Inc (IOBTQ) reported on that line in every period on record.